GENinCode Plc (AIM:GENI)
London · Delayed Price · Currency is GBP · Price in GBX 1.108
+0.058 (5.48%)
Mar 26, 2026, 3:58 PM GMT
GENinCode Market Cap
GENinCode has a market cap or net worth of 7.91 million as of March 26, 2026. Its market cap has decreased by -22.36% in one year.
Market Cap
7.91M
Enterprise Value
5.66M
Revenue
2.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.11
Market Cap Chart
Since July 22, 2021, GENinCode's market cap has decreased from 40.72M to 7.91M, a decrease of -80.58%. That is a compound annual growth rate of -29.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 7.91M | 14.84% |
| Dec 31, 2025 | 6.89M | 2.39% |
| Dec 31, 2024 | 6.72M | 33.68% |
| Dec 29, 2023 | 5.03M | -32.26% |
| Dec 30, 2022 | 7.43M | -76.15% |
| Dec 31, 2021 | 31.14M | -23.53% |
| Jul 22, 2021 | 40.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.19B |
| GSK plc | 79.07B |
| Haleon | 32.06B |
| Smith & Nephew | 10.24B |
| Genflow Biosciences | 9.91M |
| Oxford BioDynamics | 9.01M |
| RUA Life Sciences | 8.38M |
| Verici Dx | 7.95M |